Twist Bioscience (TWST) Long-Term Investments (2021 - 2026)

Twist Bioscience has reported Long-Term Investments over the past 5 years, most recently at $68.1 million for Q1 2026.

  • Quarterly Long-Term Investments changed N/A to $68.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $68.1 million through Mar 2026, changed N/A year-over-year, with the annual reading at $54.3 million for FY2025, 3463.08% up from the prior year.
  • Long-Term Investments was $68.1 million for Q1 2026 at Twist Bioscience, up from $54.3 million in the prior quarter.
  • Over five years, Long-Term Investments peaked at $68.1 million in Q1 2026 and troughed at $1.5 million in Q3 2024.
  • The 4-year median for Long-Term Investments is $54.3 million (2025), against an average of $43.9 million.
  • The largest YoY upside for Long-Term Investments was 3463.08% in 2025 against a maximum downside of 3463.08% in 2025.
  • A 4-year view of Long-Term Investments shows it stood at $30.6 million in 2022, then crashed by 95.01% to $1.5 million in 2024, then soared by 3463.08% to $54.3 million in 2025, then increased by 25.31% to $68.1 million in 2026.
  • Per Business Quant, the three most recent readings for TWST's Long-Term Investments are $68.1 million (Q1 2026), $54.3 million (Q4 2025), and $54.3 million (Q3 2025).